About Zai Lab
Zai Lab is a company based in Shanghai (China) founded in 2013.. Zai Lab has raised $160 million across 3 funding rounds from investors including Kleiner Perkins, Orbimed and Qiming Venture Partners. The company has 1,870 employees as of December 31, 2024. Zai Lab offers products and services including Transformative Medicines and Innovative Therapies. Zai Lab operates in a competitive market with competitors including Jazz Pharmaceuticals, C4 Therapeutics, Erasca, MiRagen and Mereo BioPharma, among others.
- Headquarter Shanghai, China
- Employees 1870 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Zai Lab Ltd.
-
Annual Revenue
$400.44 M (USD)49.09as on Dec 31, 2024
-
Net Profit
$-258.8 M (USD)23.42as on Dec 31, 2024
-
EBITDA
$-262.67 M (USD)27.27as on Dec 31, 2024
-
Total Equity Funding
$160 M (USD)
in 3 rounds
-
Latest Funding Round
$30 M (USD), Series C
Jun 30, 2017
-
Investors
Kleiner Perkins
& 8 more
-
Employee Count
1870
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Zai Lab
Zai Lab is a publicly listed company on the HKEX with ticker symbol 9688 in Hong Kong, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Zai Lab
Zai Lab offers a comprehensive portfolio of products and services, including Transformative Medicines and Innovative Therapies. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Develops treatments for oncology and infectious diseases through research.
Focuses on immunology and neuroscience solutions via clinical pipelines.
Unlock access to complete
Unlock access to complete
Leadership Team
36 people
Software Development Team
8 people
Human Resources and Administration
8 people
Operations Team
8 people
Finance and Accounting
5 people
Senior Team
4 people
Sales and Marketing
4 people
Product Management Team
3 people
Unlock access to complete
Funding Insights of Zai Lab
Zai Lab has successfully raised a total of $160M across 3 strategic funding rounds. The most recent funding activity was a Series C round of $30 million completed in June 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series C — $30.0M
-
First Round
First Round
(27 Aug 2014)
- Investors Count 9
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2017 | Amount | Series C - Zai Lab | Valuation |
investors |
|
| Jan, 2016 | Amount | Series B - Zai Lab | Valuation |
investors |
|
| Aug, 2014 | Amount | Series A - Zai Lab | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Zai Lab
Zai Lab has secured backing from 9 investors, including venture fund and institutional investors. Prominent investors backing the company include Kleiner Perkins, Orbimed and Qiming Venture Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are made by OrbiMed in global healthcare innovations across biopharmaceuticals and related fields.
|
Founded Year | Domain | Location | |
|
Venture capital and private equity firm
|
Founded Year | Domain | Location | |
|
Early-stage and late-stage biotech and finance companies are funded.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Zai Lab
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Zai Lab
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Zai Lab Comparisons
Competitors of Zai Lab
Zai Lab operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, C4 Therapeutics, Erasca, MiRagen and Mereo BioPharma, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Small-molecule drugs for cancer treatment are developed via Degronimid platform.
|
|
| domain | founded_year | HQ Location |
Small molecule therapeutics for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
MicroRNA-based therapeutics are developed for treating multiple diseases.
|
|
| domain | founded_year | HQ Location |
Therapeutics for cancer and rare diseases are developed.
|
|
| domain | founded_year | HQ Location |
Targeted therapeutics for cancer, metabolic, and inflammatory diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Zai Lab
Frequently Asked Questions about Zai Lab
When was Zai Lab founded?
Zai Lab was founded in 2013 and raised its 1st funding round 1 year after it was founded.
Where is Zai Lab located?
Zai Lab is headquartered in Shanghai, China.
Is Zai Lab a funded company?
Zai Lab is a funded company, having raised a total of $160M across 3 funding rounds to date. The company's 1st funding round was a Series A of $30M, raised on Aug 27, 2014.
How many employees does Zai Lab have?
As of Dec 31, 2024, the latest employee count at Zai Lab is 1,870.
What is the annual revenue of Zai Lab?
Annual revenue of Zai Lab is $400.44M as on Dec 31, 2024.
What does Zai Lab do?
Zai Lab was founded in 2013 in Shanghai, China, within the biotechnology sector. Innovative drugs targeting anti-cancer and anti-inflammatory conditions are developed, including antibody-based therapies for hepatocellular carcinoma and lung cancer. Additional products address asthma, chronic obstructive pulmonary disease, inflammatory bowel disease, and graft versus host disease. Operations center on research and development of these therapeutic solutions in the pharmaceutical industry.
Who are the top competitors of Zai Lab?
Zai Lab's top competitors include Jazz Pharmaceuticals, C4 Therapeutics and Erasca.
What products or services does Zai Lab offer?
Zai Lab offers Transformative Medicines and Innovative Therapies.
Is Zai Lab publicly traded?
Yes, Zai Lab is publicly traded on HKEX under the ticker symbol 9688.
Who are Zai Lab's investors?
Zai Lab has 9 investors. Key investors include Kleiner Perkins, Orbimed, Qiming Venture Partners, Vivo Capital, and Rock Springs Capital.
What is Zai Lab's ticker symbol?
The ticker symbol of Zai Lab is 9688 on HKEX.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.